Porton Pharma Solutions (300363.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters of the year amounting to 21...
According to the Wisepoint Finance APP, Porton Pharma Solutions (300363.SZ) released the third quarter report for 2024. The company's revenue for the first three quarters amounted to 2.125 billion yuan, a decrease of 30.02% year-on-year; the net loss attributable to shareholders of the listed company was 0.206 billion yuan; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.213 billion yuan; basic loss per share was 0.38 yuan/share.
